Submitted in Fulfilment for the Doctor of Philosophy Degree in Pharmaceutical Science (Pharmaceutics) Thesis Presented By
|
|
- Jeremy Davidson
- 5 years ago
- Views:
Transcription
1 PHARMACOECONOMIC STUDY TO DETERMINE THE CLINICAL EFFECT OF DEFFERENT ANTIBIOTICS INCLUDED IN THERAPUTIC REGIMENS USED IN THE TREATMENT OF PATIENTS SUFFERING OTITIS MEDIA, THEIR COST, AND THEIR RELATION WITH THE PATIENTS RESPONSE Submitted in Fulfilment for the Doctor of Philosophy Degree in Pharmaceutical Science (Pharmaceutics) Thesis Presented By Noha Mohamed Fathy Abd El Fattah El Adawy Under The Supervision of Prof. Dr. Saadia A. Tayel Prof. of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy Cairo University Prof. Dr. Mohamed A. El-Nabarawi Prof. of Pharmaceutics and Industrial Pharmacy Faculty of Pharmacy Cairo University Dr. Nirmeen A. Sabry Assistant Prof. of Clinical Pharmacy Faculty of Pharmacy Cairo University Dr. Ahmed Shawki Mohamed Assistant Prof. of E.N.T Faculty of Medicine Cairo University Cairo University Faculty of Pharmacy Department of Pharmaceutics (2012)
2 ACKNOWLEDGMENT I would like to express my deepest gratitude to Professor Dr. Saadia Ahmed Tayel, Professor of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, who enriched this work by her knowledge and offered me much of her time, effort and help. I would also like to express my greatest appreciation to Professor Dr. Mohamed Ahmed El Nabarawi, Professor of Pharmaceutics and Industrial Pharmacy, Cairo Universityfor his continuous guidance, gracious supervision and support throughout the execution of this work. I feel greatly indebted to Dr. Nirmeen Ahmed Sabry, Assistant Professor of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, for her tremendous help, time and effort. I would also like to express my heartily thankfulness for Dr. Ahmed Shawki Mohamed, Assistant Professor of E.N.T, Faculty of Medicine, Cairo University, for his generous help and invaluable advice all through the way. i
3 Table of Contents List of Tables...iii List of Figures......vii List of Abbreviations...ix Abstract...xi General Introduction CHAPTER I: Determination of Cost Effective Antibiotic Therapy for Patients Suffering Acute Otitis Media... Introduction.31 Experimental 33 Results Economic Study...69 Discussion...78 CHAPTER II: Determination of the Cost Effective Drug Therapy for Patients suffering Otitis Media with Effusion... Introduction...95 Experimental..96 Results Economic Study Discussion Conclusion and Recommendations References Arabic Summary ii
4 List of Tables Table# Title Table I : Table II : Table III : Table IV : Table V: Table VI: Table VII: Table 1: Table 2: Table 3: Table 4: Table 5: Table 6: Table 7: Table 8: Table 9: Table 10: Diagnostic feature of OME and AOM Relationship between the age of the child and the possibilities of using antibiotics. Microbiology of AOM Suggested antimicrobial therapy for AOM The process used to identify situations when a pharmacoeconomic analysis is needed. Examples of direct and direct non-medical costs Some major examples of indirect costs The demographic data of the patients recruited in this study Average Pain Score during the First Visit Parameter Average Hear Loss Score during the First Visit Average Body Temperature C (SD) during the First Visit Tympanic Membrane Examination during the First Visit Nasal Examination during the First Visit The Percentage of the Patients who Reported Pain Improvement during the Second Visit Pain Improvement using VAS for Patients Older than 3 Years Old During the Second Visit The Improvement in the Hear Loss during the Second visit Compared with the First Visit. The average Body Temperature during the First and the second Visits iii
5 Table 11: Table12: Table 13: Table 14: Table 15: Table 16: Table 17: Table 18: Table 19: Table 20: Table 21: Table 22: The Percentage of Patients Showing Improvement in the Clinical Picture of the Tympanic Membrane during the Second Visit The Percentage of the Patients showing Improvement in the Ear Discharge during the Second Visit The Number of patients still suffering from nasal discharge during the second visit. The Overall Number and Percentage of Completely Cured Patients in each Drug Group. Post-hooked Chi-Square Test to Show the Difference between the Number of Patients Cured in the Azithromycine and other Patients Belonging to the Other Study Groups. Post-hooked Chi-square Test Showing the Difference between the Number of Patients Cured between the Ampicillin/Clavulanic Acid Group and Study Groups except the Azithromycine Group. Post-hooked Chi-square Test Showing the Difference between the Number of Patients Cured between the Ampicillin group and both of Cephradine and Cefprozil groups. Post-hooked Chi-square Test Showing the Difference between the Number of Patients Cured between the Cephradine and Cefprozil Groups. The Pain Control Pattern among the Five Drug Groups. Post-hooked Chi-square Test for the Pain Control. Cost calculation including volume per unit, recommended dose, price per unit and price for ten days treatment Calculation of the therapeutic failure cost including the calculation of the extra physician visit and the extra cost of the new drug prescribed iv
6 Table 23: Table 24: Table 25: Table 26: Table 27: Table 28: Table 29: Calculation of net cost- effectiveness Calculation of savings gained by using the medication. Cost effectiveness of antibiotic regimens used in the treatment of AOM. The Demographic Data of the Recruited Patients. Average Hear Loss Score During the First Visit. Average Body Temperature C (SD) During the First Visit. Ear Drum Examination During the First Visit. Table 30: Table 31: Table 32: Table 33: Table 34: Table 35: Table 36: Table 37: Table 38: Table 39: Table 40: Table 41: Table 42: Table 43: Table 44: Middle Ear effusionexamination During the First Visit. Tympanometric Examination During the first Visit. Average Hear Loss Score During the Second Visit. The Average Body Temperature during the First and the Second Visits. Ear Drum Examination During the Second Visit Middle Ear Effusion Examination During the Second Visit Tympanometric Examination During the Second Visit Average Hear Loss Score During the Third Visit Ear Drum Examination During the Third Visit Middle Ear EffusionExamination During the Third Visit Tympanometric Examination During the Third Visit Average Hear Loss Score During the Fourth Visit Ear Drum Examination During the Fourth Visit Middle Ear EffusionExamination During the Fourth Visit Post hock Test for the Assessment of Middle Ear Effusion in the Three Drug v
7 Groups During the Fourth Visit Table 45: Table 46: Table 47: Table 48: Table 49: Table 50: Table 51: Table 52: Table 53: Tympanometric Examination During the Fourth Visit Adverse Drug Reactions Reported by the Patients in the Three Drug Groups The Post Hocked Chi-square Test for the Adverse Drug Reactions Affected Patients in the Three Drugs Under Study The Surgical Score in the Three Drug Groups Cost Calculation Including Volume/unit, Recommended dose, Price/unit and Price for 2 Weeks Treatment Calculation of the Cost of the Side Effects Calculation of the Net Costs Calculation of Savings Gained by Using the Studied Medication Regimens The Cost Effectiveness Results of the Drug Regimens Used to Treat OME vi
8 List of Figures Figure No. Figure I Figure II Figure III Figure IV Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Figure 6 Figure 7 Figure 8 Figure 9 Figure 10 Figure 11 Figure 12 Figure 13 Figure 14 Figure 15 Figure 16 Title The Eustachian Tube in both Adults and Infants Standard Gamble for a Chronic Health State Algorithm for the Choice of the Pharmacoeconomic Methodology Process for Incorporating Pharmacoeconomic Evaluation in Formulary Decision. The Percentage of Patients Showed Pain Improvement in each Drug Group The Total Percentage of the Patients who Showed Pain Improvement Among the Whole Studied Sample The Percentage of Patients Showed Improvement in their Hear Loss in each Antibiotic Group The Total Percentage of the Patients who Showed Hear Loss Improvement among the Whole Studied Sample Percentage of Patients with Red Tympanic Membrane before and after Initiation of the therapy Percentage of Patients with Bulging Tympanic Membrane before and after Initiation of the Therapy The Percentage of Patients Showed Improvement in the Tympanic Membrane in each Group Separately The Total Percentage of Patients who Showed Improvement in their Tympanic Membrane Percentage of the Patients with no Ear Discharge before and after Initiation of the Therapy Percentage of Patients Showed an Improvement in the Ear Discharge in Each group. The Percentage of the Patients with Nasal Discharge before and after Initiation of the Therapy The Percentage of Patients Showed Improvement in the Nasal Discharge in Each Group The Percentage of Patients Showed improvement in the Nasal Discharge The Percentage of Patients Reporting Pain Control after Day One The Percentage of Patients Reporting Pain Control after Day Two The Percentage of Patients Reporting Pain Control after Day Three vii
9 Figure 17 Figure 18 Figure 19 Figure 20 Figure 21 Figure 22 Figure 23 Figure 24 Figure 25 Figure 26 Figure 27 Figure 28 Figure 29 The frequency of the Possible Answer to the Question Discovering the Regular Use of the Medication The Frequency of the Possible Answer to the Question Discovering the Patients/Caregivers Beliefs Regarding the Efficacy of the Medication The Patients/Caregivers Opinion Regarding the Suitability of the Price of the Medication Patients Cured after Two-Week Therapy Percentage of Patients Recovered after Four Weeks Therapy Percentage of Patients Recovered after Six Weeks Therapy Total Number of Patients Completely Cured After Six Weeks in each Drug Group Percentage of the Total Number of Patients Reported No Adverse Drug Reactions The Number of Patients Suffered Adverse Drug Reaction in Each Drug Group Percentage of Patients Underwent Surgical Procedure The Frequency of the Different Answers of the Second Question: do you believe that the medication is really helping the patients? The Frequency of the Different Answers of the Third Question: do you believe the price of medication is suitable? The Percentage of the Patients who Believed that the Price of the Medication was Suitable viii
10 List of Abbreviations 1 (X 2 ) Pearson s Chi-squared Test 2 AAFP American Academy of Family Physicians 3 AAP American Academy of Pediatrics 4 ABCS Active Bacterial Core Surveillance 5 AHCPR Agency for Health Care Policy and Research 6 ANOVA Analysis of Variance test 7 AOM Acute Otitis Media 8 C Degree Celsius 9 C/E Cost Effectiveness ratio 10 CBA Cost-Benefit Analysis 11 CCA Cost-Consequence Analysis 12 CDCP Centre of Disease Control and Prevention 13 CEA Cost-Effectiveness Analysis 14 CMA Cost-Minimization Analysis 15 COI Cost of Illness 16 CSOM Chronic Suppurative Otitis Media 17 CSS Cigarette Smoke Solution 18 CUA Cost-Utility Analysis 19 DALYs Disability Adjusted Life Years 20 E.N.T Ear, Nose and Throat 21 ECHO Economic Clinical Humanistic Outcomes 22 EGFR Epidermal Growth Factor Receptor 23 H. influenzae Haemophilus influenzae 24 HMEECs Human Middle Ear Epithelial Cells 25 HMO Health Maintenance Organization 26 HRQoL Health Related Quality of Life 27 HYEs Healthy Year Equivalents 28 ICA Incremental Cost Analysis 29 ICER Incremental Cost Effectiveness Ratio 30 Ig Serum immunoglobulin 31 L.E Egyptian pound 32 M. catarrhalis. Moraxella catarrhalis ix
11 33 MCOs Managed Care Organizations 34 MEE Middle ear effusion 35 mrna Messenger RNA 36 MUC5AC Human mucin gene 37 NSAIDs Non-Steroidal Anti-Inflammatory Drugs 38 OM Otitis Media 39 OME Otitis Media with Effusion 40 PAS Paediatric academic society 41 PE Pharmacoeconomics 42 PNSP Penicillin non-susceptible Pneumococcal 43 QALY Quality Adjusted Life Year 44 QHIDB Quebec Health Insurance Database 45 RCTs Randomized Clinical Trials 46 S. pneumoniae Streptococcus pneumonia 47 SD Standard deviation 48 SPSS Statistical Package for Social Science 49 TM Tympanic Membrane 50 TNF-α Tumor necrosis factor-alpha 51 U Mann Whitney test 52 UK United Kingdom 53 URI Upper Respiratory Infection 54 URTI Upper Respiratory Tract Infection 55 V.T Ventilation Tube 56 VAS Visual Analogue Score x
12 ABSTRACT Introduction and Objectives Otitis media (OM) is a common illness affecting both infants and children, often multiple times during the first few years of life. The aim of this study is to determine the most cost effective drug for treatment of otitis media. Chapter One: Determination of Cost Effective Antibiotic Therapy for Patients Suffering Acute Otitis Media In Abouelreesh children hospital, 150 child aged 2-6 with ear pain were randomly divided into 5 groups A, B, C, D and E to be given amoxicillin/clavulanic acid, ampicillin, cephradine, cefprozil and azithromycin respectively for 10 days.amoxicillin/clavulanic acid represents the highest percentage of patients improved in the degree of pain (31%), hearing loss (32%), tympanic membrane (31%), and running nose (31%) among the whole sample under study. Although amoxicillin/clavulanic acid showed the highest percentage of cured patients (70%), yet there was no significant difference with ampicillin or Cephradine. Showing the lowest number of cured patients, azithromycin (15.4%) showed no significant difference with cefprozil (32%). There was no significant difference. Using cost effectiveness analysis model, amoxicillin/clavulanic acid showed the highest effectiveness value (0.7) although ampicillin provided the maximum savings. Chapter Two: Determination of the cost effective drug therapy for patients suffering otitis media with effusion Forty five child aged 2-6 suffering hearing loss were randomly divided into 3 groups X, Y and Z to be given phenadone syrup, cephradine/phenadone and amoxicillin/clavulanic acid/phenadone respectively. Patients were re-assessed every 2 weeks for 6 weeks. Uncured patients were subjected to myringotomy. There was no significant difference between the 3 groups in the post assessment of hear loss, ear-drum examination or tympanograph during either the second, third or fourth visits. No significant difference was detected in the middle ear effusion during the second or third visits. xi
13 The percentage of patients cured in the phenadone group was (31%), cephradine/phenadone (35%) and 34% in the amoxicillin/clavulanic acid/phenadone.28% of the total patients who experienced side effects were belonging to the phenadone group,33% in the phenadone/amoxicillin/clavulanic acid group and 39% in the phendone/cephradine group. Un cured patients (20%) were subjected to myringotomy with no significant difference between the 3 groups. Phenadone showed the highest cost saving (4, L.E/patient), with cost effectiveness/patient of 40.54L.E. Conclusion Amoxicillin/clavulanic acid is the recommended most cost effective drug therapy for treatment of patients suffering Acute Otitis Media while phenadone (without the addition of antibiotics) is the most cost effective choice for treatment of patients suffering Otitis Media with Effusion. xii
14 GENERAL INTRODUCTION Anatomically, an ear is a vertebrate organ of hearing responsible for sensing and collecting sounds as well as maintaining equilibrium. The human ear is divided into three anatomical divisions (1-2) 1. Outer ear 2. Middle ear 3. Inner ear Ear infection Ear infections can affect anyone, but mostly affect children. (1-2) The most common type of ear infection affects the middle ear. The medical term for a middle ear infection is Otitis Media (OM). (3) The middle ear infection can affect one or both ears. (3) The main types of infection are listed below. (4) 1. Acute otitis media (AOM) AOM is defined as the recent, abrupt onset of middle ear effusion accompanied by signs or symptoms of inflammation of the middle ear. (5) 2. Otitis media with effusion (OME) or (Glue Ear) It is also called secretory otitis media. It is defined as inflammation of the middle ear, accompanied by the accumulation of fluid in the middle ear cleft without the symptoms and signs of acute inflammation. OME is often asymptomatic and earache is relatively uncommon. (6) OME usually follows an episode of acute AOM. (6) 3. Chronic suppurative otitis media (CSOM) CSOM is assumed to be a complication of AOM. (7) Frequent upper respiratory tract infections and poor socioeconomic conditions (overcrowded housing, and poor hygiene and nutrition) (7) may be related to the development of CSOM. (8-9) CSOM represents the most frequent cause of moderate hearing loss (40 60 db). (10) Persistent hearing loss during the first two years may increase learning disabilities and poor scholastic performance. (11) Progressive hearing loss may occur among those in whom infection persists. Less frequently, spread of infection may lead to life threatening complications such as intracranial infections and acute mastoiditis. (12) 1
15 Mechanism of ear infection The small space behind the eardrum in the middle ear is normally filled with air. It is connected to the back of the throat by a tiny channel called the Eustachian tube. (13) Figure I The Eustachian tube in both adults and infants The tissues surrounding the Eustachian tube swell due to an upper respiratory infection, allergies, or dysfunction of the tubes. (14) The Eustachian tube remains blocked most of the time. The air present in the middle ear is slowly absorbed into the surrounding tissues. A strong negative pressure creates a vacuum in the middle ear. The vacuum reaches a point where fluid from the surrounding tissues accumulates in the middle ear. (14) The accumulated fluid may become infected. It has been found that dormant bacteria behind the Tympanum (eardrum) multiply when the conditions are ideal infecting the middle ear fluid. (14) When the middle ear becomes acutely infected (AOM), pressure builds up behind the ear drum. In severe cases, the tympanic membrane may rupture. Once perforated, the pus drains out into the ear canal. In most cases, a burst eardrum heals by itself. (14) Risk Factors for OM in children 1. Anatomically: Acute middle ear infections are most common in children. (15) Children below the age of seven years are much more prone to OM since the Eustachian tube is shorter and at more of a horizontal angle than in the adult ear (figure 1). Children aged less than 10 accounts for three quarters of those affected. (6) 2. Immunologically: They also have not developed the same resistance to viruses and bacteria as adults. (1) 2
16 3. Smoke: Several studies have shown a strong correlation between parental smoking and OME. (16-17) A large cohort study showed a marked dose-dependent effect. (16) In 1999, Glasziou et al. (18) reported in a study conducted over two years and tested approximately 3,000 children from birth to age two that about 33% of the children exposed to higher than average levels of vehicle emissions developed ear infections sometime during the study. (18) 4. The use of formula milk (rather than breast milk) (19) and feeding in a flat, supine position. (19) 5. Children who suffer from frequent coughs and colds. (19) 6. Boys are more susceptible to OME than girls, as are children in day care and those with older siblings. (19) 7. Children with certain genetic conditions, such as Down's syndrome. (20-21) Children with an anatomical abnormality affecting the face, such as a cleft palate are highly susceptible to OME. (20-21) Clinical Assessment and Diagnosis 1. AOM Ear related symptoms may include earache, tugging or rubbing of the ear, (3) irritability with loss of appetite, (3, 22) restless sleep and fever. (22) Children may also have a history of cough and rhinorhea symptoms which are reported to increase the risk of AOM. Earache, however, is the single most important symptom. (23) Otoscopic typical appearances of AOM include bulging tympanic membrane with loss of the normal landmarks, change in colour (typically red or yellow), and poor mobility. (24) Additionally, AOM may leave a middle ear effusion for a variable period of time following resolution of the acute symptoms - the two forms of OM (AOM and OME) should be considered part of a disease continuum. (25-26) 2. OME Most children have middle ear effusions and are often asymptomatic. (27) There is a minority in whom effusions persist over months or years causing hearing loss which in turn potentially impairs speech development and educational performance. (28-29) 3
17 Deafness, in small children, is often mistaken for lack of attention or even behavior problems. (3) Rates of bilateral OME are twice as high during winter than summer. (30) Common cold and OME are the most frequent diseases of infancy, characterized by a multifactorial pathogenesis. (31) There is also an association between OME and respiratory infections. (32) Newborns in neonatal intensive care units have a high incidence of OME, which is also more prevalent in the first than second year of life. (33) OME is diagnosed if there is middle ear effusion on pneumatic otoscopy with no signs of acute inflammation. (27) Evidence of middle ear effusion consists of the presence of either: At least two tympanic membrane abnormalities (abnormal colour such as yellow, amber, or blue; opacification other than due to scarring; and decreased or absent mobility) (27) otoscopy typically showing a retracted/concave tympanic membrane with a colour change (typically yellow or amber). (34) Air bubbles or an air/fluid level may be present and, while not typical, fullness or bulging may be visualized. Pneumo-otoscopy will demonstrate reduced or absent mobility. (34) Table I: Diagnostic feature of OME and AOM Earache, Fever, Irritability Middle ear effusion Opaque drum Bulging drum Impaired drum mobility Hearing loss OME Usually absent Present may be absent Usually absent present Usually present AOM Present Present Present May be present present present Technical diagnostic aids In addition to clinical signs and symptoms, certain technical aids can assist in the diagnosis of OM. (35) 4
18 1. Tympanography: is quite valuable in defining the presence of middle ear effusion. However, tympanography can be difficult to perform because obtaining a seal is often quite difficult, especially in children younger than 6 months of age. (35) 2. Pneumatic Otoscopy: is the most practical diagnostic modality for AOM. (35) The pneumatic otoscope should be checked to assure that the bulb is current and the light is bright and white in color. If a yellow or orange bulb is used, the tympanic membrane will appear inflamed. (35) Medical treatment 1. Pharmacological Therapy 1.1. Treatment of AOM AOM has received much attention in recent years. (36) Studies have shown that this condition to be over diagnosed and, hence, over treated as much 50% of the time by clinicians caring for children (37, 38) and there is a great dilemma concerning the different treatment strategies Antibiotic treatment There is wide variation in the use of antibiotics between doctors in different countries, from as low as 31% of cases with AOM in the Netherlands to as high as 98% in Australia and the United States. (39) Antibiotics were previously routinely immediately started, this practice is diminishing. Antibiotics do shorten the illness by around 1/3 compared to the illness's natural history, but this is a small gain for most children. (40) However, very young children, those with bilateral OM, and those with a high fever are likely to have a more severe course and hence benefit more from antibiotics. (41, 42) Many guidelines now suggest deferring the start of antibiotics for 24 to 72 hours. (43) This results in 2 out of 3 children avoiding the need to start antibiotics,(44) and no adverse effect on long-term outcomes for those whose treatment is deferred.(45) A meta-analysis of antibiotic versus placebo trials showed that antibiotics do not influence resolution of pain within 24 hours of presentation. At two to seven days after presentation, only 14% of children in control groups still had pain, although early use of antibiotics reduced the risk of pain by about 40%. (46) Children with AOM would need to be treated with a broad spectrum antibiotic rather than no antibiotic treatment to avoid a clinical failure. (46) Antibiotics in comparison to placebo and observational 5
19 treatment may have a modest benefit on symptom resolution and failure rates, as variously defined, in children over the age of two years with AOM. (47) Delayed antibiotic treatment In a delayed treatment trial, 315 children aged six months to 10 years were allocated to one of two treatment strategies: immediate antibiotic or delayed antibiotic. (45) The outcome measures were symptom resolution, absence from nursery or school and paracetamol consumption. The main conclusions from this trial were that immediate antibiotics provided symptomatic benefit mainly after the first 24 hours, increase the incidence of diarrhea by 10%, only 24% of the parents in the delayed prescription group used antibiotics and a wait and see approach in the management of AOM is acceptable to most parents and results in a 76% reduction in the use of antibiotic prescriptions. (45) A wait and see strategy is the observation of the patient without antibiotic therapy. It is an option clinicians may consider under certain circumstances, as outlined in Table 2. (48) This principle is based on data generated over the last decades documenting the clinical resolution of OM among children given placebo or no therapy and on studies comparing response between children receiving placebo or no therapy and children receiving antimicrobials. (48-50) Only 2 randomized trials (51), (25) have addressed the issue of school absence: One of the two trials found no significant difference between immediate versus delayed antibiotic therapy, (51) and the other reported a significant decrease of 1.5 days for children who received antibiotic versus placebo. (25) In both studies the mean duration of pain or crying was also reduced by 0.5 to 1.0 day. Table II: Relationship Between the Age of the Child and the Possibilities of Using Antibiotics. Age of child If diagnosis of AOM is certain If diagnosis of AOM is uncertain < 6 months Antibiotics Antibiotics 6 months 2 year Antibiotics Antibiotics if severe illness Observe if non-severe illness 2 years Antibiotics if severe illness Observe Observe if non-severe illness 6
20 Choice and duration of antibiotic therapy The antimicrobial therapy of AOM depends, of course, on the microbiology of the infection (Table 3). A large number of studies (38, 52-54) have established that two organisms, Streptococcus pneumoniae and Haemophilus influenzae, are the principal aetiological agents in OM bacterial infection. (52) Recently, it was reported that, 35% to 50% of cases of AOM are caused by H. influenzae, 25% to 40% by S. pneumoniae, and 5% to 10% by Moraxella catarrhalis a gram-negative, aerobic micro-organism. (38) A negligible number of cases are due to other bacteria. Viruses have been identified as the sole cause of infection in 5% to 15% of cases. (53) With S. pneumoniae and H. influenzae, broad spectrum antibiotics such as amoxicillin, or amoxicillin with clavulanic acid, are the drugs of choice if an antibiotic is to be used. (38) Cefaclor, cotrimoxazole, trimethoprim and erythromycin can be effective, but are less safe than amoxicillin. (54) Table III: Microbiology of AOM The Organism Cases in which organism is causative Haemophilus influenzae 35% 50% Streptococcus pneumoniae 25% 40% Moraxella catarrhalis 5% 10% This recommendation is based on the recognition that amoxicillin is not only effective but also has a low incidence of side effects, is cost-effective, and, by virtue of its taste, helps to assure good compliance. (55) The suggested antimicrobial therapy for AOM is outlined in Table 4. Children who have uncertain allergy to beta-lactams or non-anaphylactic allergy are advised to take an oral cephalosporin. (55) While children with a history of anaphylaxis or severe allergy to beta-lactams warrant treatment with one of the following: azithromycin, clarithromycin, trimethoprim-sulfamethoxazole, or erythromycinsulfisoxazole. (5) Viruses 5% 15% No growth of bacterial agents 1% 15% 7
PAEDIATRIC ACUTE CARE GUIDELINE. Otitis Media
Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE Otitis Media Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be read in
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Acute Otitis Media. These podcasts are designed to give medical students an overview of key topics in pediatrics. The
More informationDefinitions of Otitis Media
Definitions of Otitis Media T H I S T E A C H I N G P R E S E N T A T I O N F O R T H E I S O M W E B S I T E H A S B E E N P R E P A R E D B Y T A L M A R O M, M D A N D S H A R O N O V N A T T A M I
More informationChoosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens
Choosing an appropriate antimicrobial agent Consider: 1) the host 2) the site of infection 3) the spectrum of potential pathogens 4) the likelihood that these pathogens are resistant to antimicrobial agents
More informationEvelyn A. Kluka, MD FAAP November 30, 2011
Evelyn A. Kluka, MD FAAP November 30, 2011 > 80% of children will suffer from at least one episode of AOM by 3 years of age 40% will have > 6 recurrences by age 7 years Most common diagnosis for which
More informationUPPER RESPIRATORY TRACT INFECTIONS. IAP UG Teaching slides
UPPER RESPIRATORY TRACT INFECTIONS 1 INTRODUCTION Most common problem in children below 5 years. In this age group they get about 6 8 episodes per year. It includes infections of nasal cavity, throat,
More informationDefinition. Otitis Media with effusion (OME)
Otitis Media. 1 Dr,wegdan saeed ALFHAL 2 Definition Acute Otitis Media (AOM) acute onset of symptoms, evidence of a middle ear effusion, and signs or symptoms of middle ear inflammation. Otitis Media with
More informationAcute Otitis Media, Acute Bacterial Sinusitis, and Acute Bacterial Rhinosinusitis
Acute Otitis Media, Acute Bacterial Sinusitis, and Acute Bacterial Rhinosinusitis This guideline, developed by Larry Simmons, MD, in collaboration with the ANGELS team, on October 3, 2013, is a significantly
More informationEvidence Based Practice Presentation
Evidence Based Practice Presentation Does the assessment of tympanic membrane mobility using pneumatic otoscopy reduce the diagnosis of Acute otitis media & otitis media with effusion in children? Ashley
More informationOtitis Media. Anatomy & Hearing Our ears are very specialized organs that allow us to hear and keep our balance.
Otitis Media Introduction Otitis media is a middle ear infection. 75% of all children experience at least one episode of otitis media before they turn 3 years old. If otitis media is left untreated, it
More informationACUTE PAEDIATRIC EAR PRESENTATIONS PROF IAIN BRUCE PAEDIATRIC OTOLARYNGOLOGIST & ADULT OTOLOGIST
www.manchesterchildrensent.com ACUTE PAEDIATRIC EAR PRESENTATIONS PROF IAIN BRUCE PAEDIATRIC OTOLARYNGOLOGIST & ADULT OTOLOGIST A CHILD WITH EARACHE UNCOMPLICATED AOM ACUTE OTITIS MEDIA Acute otitis media
More informationGuideline Review. Clinical Practice Guideline on the Diagnosis and Management of Acute Otitis Media BCC LAM, YC TSAO, Y HUI.
HK J Paediatr (new series) 2006;11:76-83 Guideline Review Clinical Practice Guideline on the Diagnosis and Management of Acute Otitis Media BCC LAM, YC TSAO, Y HUI Introduction Acute otitis media is a
More informationRespiratory tract infections. Krzysztof Buczkowski
Respiratory tract infections Krzysztof Buczkowski Etiology Viruses Rhinoviruses Adenoviruses Coronaviruses Influenza and Parainfluenza Viruses Respiratory Syncitial Viruses Enteroviruses Etiology Bacteria
More informationWhere kids come first. Your Child and Ear Infections
17 Where kids come first Your Child and Ear Infections How common are ear infections? Infection of the middle ear, or otitis media, is the most common affliction requiring medical therapy for children
More informationMIDDLE EAR INFECTIONS
MIDDLE EAR INFECTIONS A Guide to Treatment and Prevention A Common Problem Middle ear infections are due to a buildup of fluid in the middle ear. This is a common problem in younger children, whose ears
More informationClinical Practice Guideline: Tonsillectomy in Children, Baugh et al Otolaryngology Head and Neck Surgery, 2011 J and: 144 (1 supplement) S1 30.
Pediatric ENT Guidelines Jane Cooper, FNP, CORLN References: Clinical Practice Guideline: Tympanostomy tubes in children, Rosenfeld et al., American Academy of Otolaryngology Head and Neck Surgery Foundation
More informationComparative Efficacy and Safety Evaluation of Cefaclor VS Amoxycillin + Clavulanate in Children with Acute Otitis Media (AOM)
Special Article Comparative Efficacy and Safety Evaluation of Cefaclor VS Amoxycillin + Clavulanate in Children with Acute Otitis Media (AOM) Mukesh Aggarwal, Ramanuj Sinha 1, M. Vasudeva Murali 2, Prita
More informationAll About RSV (Respiratory Syncytial Virus)
All About RSV (Respiratory Syncytial Virus) A Guide for Parents What is RSV? RSV stands for respiratory syncytial virus, the most frequent cause of serious respiratory tract infections in infants and children
More informationManagement of URTI s in Children
Management of URTI s in Children Robin J Green PhD Antibiotics - Dilemmas for General Practitioners Antibiotic overuse = Resistance Delay in antibiotic use = Mortality Patient expectation Employer expectation
More informationENT approach to middle ear disease in children: the evidence. Dr Trish MacFarlane MBBS, FRACS.
ENT approach to middle ear disease in children: the evidence. Dr Trish MacFarlane MBBS, FRACS. Outline: Extent of the problem. Defining the problem. Tips to improving diagnostic accuracy. Review of current
More informationPaediatric ENT problems
Paediatric ENT problems Ears Otitis media Otitis media with effusion FBs Otitis externa Ruptured TM Nose FBs Allergic rhinitis Septal perforation expistaxis Throat FB Croup Stidor Tonsillitis Paediatric
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment McCormick D P, Chonmaitree T, Pittman C, Saeed K, Friedman N R, Uchida T, Baldwin
More informationAMERICAN ACADEMY OF PEDIATRICS AND AMERICAN ACADEMY OF FAMILY PHYSICIANS. Subcommittee on Management of Acute Otitis Media
AMERICAN ACADEMY OF PEDIATRICS AND AMERICAN ACADEMY OF FAMILY PHYSICIANS CLINICAL PRACTICE GUIDELINE Subcommittee on Management of Acute Otitis Media Diagnosis and Management of Acute Otitis Media ABSTRACT.
More informationMEDICATIONS USED TO TREAT UPPER RESPIRATORY TRACT INFECTION AND COMMON COLD
MEDICATIONS USED TO TREAT UPPER RESPIRATORY TRACT INFECTION AND COMMON COLD TABLE OF CONTENT OUR TPA MODEL FOR COMPREHENSIVE PBM SOLUTION PURPOSE OF THE DRUG UTILIZATION REVIEW (DUR) BACKGROUND ABOUT UPPER
More informationBIOS222 TUTORIAL ACTIVITY SESSION 1
BIOS222 TUTORIAL ACTIVITY SESSION 1 Instructions: The Tutorial activities are designed to help you practice the concepts learned in the lecture. Read the following case studies and answer the questions
More informationGROMMET INSERTION RECURRENT ACUTE OTITIS MEDIA (WITHOUT EFFUSION) SECONDARY CARE PRIOR APPROVAL POLICY
Version: 1718.v1 Ratified by: SCCG COG Date Ratified: 05 April 2017 Name of Originator/Author: Name of Responsible Committee/Individual: IFR SCCG CCPF/ IFR Date issued: 18 April 2017 Review date: Target
More informationBond University Research Repository
Bond University Research Repository Current management of children with acute otitis media by Indonesian clinicians: a preliminary feasibility survey prior to a pragmatic clinical trial Ranakusuma, Respati
More informationTreatment of glue ear with grommets
Treatment of glue ear with grommets Information for families Great Ormond Street Hospital for Children NHS Foundation Trust This leaflet explains about glue ear, how it can be treated using grommets and
More informationUpper Respiratory Tract Infections / 42
Upper Respiratory Tract Infections 1 Upper Respiratory Tract Infections Acute tonsillitispharyngitis Acute otitis media Acute sinusitis Common cold Acute laryngitis Otitis externa Mastoiditis Acute apiglottis
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Rapenin (phenoxymethylpenicillin potassium) is indicated for the treatment of infections caused by penicillin-sensitive bacteria.
More informationADULT ONSET ACUTE OTITIS MEDIA - A PRELIMINARY REPORT Mukta Pagrani 1, Abhinav Srivastava 2, Chander Mohan 3
ADULT ONSET ACUTE OTITIS MEDIA - A PRELIMINARY REPORT Mukta Pagrani 1, Abhinav Srivastava 2, Chander Mohan 3 HOW TO CITE THIS ARTICLE: Mukta Pagrani, Abhinav Srivastava, Chander Mohan. Adult Onset Acute
More informationEar Exam and Hearing Tests
Ear Exam and Hearing Tests Test Overview A thorough evaluation of a person's hearing requires an ear exam and hearing tests. In children, normal hearing is important for language to develop correctly.
More informationKingdom of Bahrain Arabian Gulf University College of Medicine and Medical Sciences Year 6 ENT SMC Otitis Media (Dr.
Kingdom of Bahrain Arabian Gulf University College of Medicine and Medical Sciences Year 6 ENT SMC Otitis Media (Dr. Jalal Almarzooq) - Anatomy of the ear: The ear is divided into 3 parts: External ear.
More informationMiddle Ear Fluid in Young Children: Parent Guide
Vinod K. Anand, MD, FACS Nose and Sinus Clinic Middle Ear Fluid in Young Children: Parent Guide Purpose of This Booklet This booklet is about middle ear fluid in children ages 1 through 3 who have no other
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Hoberman A, Paradise JL, Rockette HE, et al. Shortened antimicrobial
More informationSubspecialty Rotation: Otolaryngology
Subspecialty Rotation: Otolaryngology Faculty: Evelyn Kluka, M.D. GOAL: Hearing Loss. Understand the morbidity of hearing loss, intervention strategies, and the pediatrician's and other specialists' roles
More informationDr Graeme Copley. Department of Paediatric Otorhinolaryngology Red Cross Children s Hospital
Prevention of middle ear infections in children Dr Graeme Copley Department of Paediatric Otorhinolaryngology Red Cross Children s Hospital Acute middle ear infections Seen mostly by primary care givers
More informationANTIBIOTICS ACUTE RHINOSINUSITIS IN CHILDREN
MARCH 2016 DRUG ANTIBIOTICS This optimal usage guide is mainly intended f primary care health professionnals. It is provided f infmation purposes only and should not replace the clinician s judgement.
More informationPOLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS
POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: July 2013 Approved by: The Drugs & Therapeutics Committee Date: April 2016 Implementation
More informationPOLICY FOR TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS
POLICY F TREATMENT OF UPPER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: Date: July 2018 The Drugs & Therapeutics Committee Implementation
More informationDiagnosis and Treatment of Respiratory Illness in Children and Adults
Page 1 of 9 Main Algorithm Annotations 1. Patient Reports Some Combination of Symptoms Patients may present for an appointment, call into a provider to schedule an appointment or nurse line presenting
More informationEar Disorders and Problems
Ear Disorders and Problems Introduction Your ear has three main parts: outer, middle and inner. You use all of them to hear. There are many disorders and problems that can affect the ear. The symptoms
More informationUpper Respiratory Tract Infections
Upper Respiratory Tract Infections OTITIS MEDIA Otitis media is an inflammation of the middle ear. There are more than 709 million cases of otitis media worldwide each year; half of these cases occur in
More informationJimmy's Got Cooties! Common Childhood Infections and How Best to Treat Them
Jimmy's Got Cooties! Common Childhood Infections and How Best to Treat Them Objectives:! Recognize and manage several infections commonly seen in Pediatric practice! Discuss best practices and current
More informationUpdate on Rhinosinusitis 2013 AAP Guidelines Review
Update on Rhinosinusitis 2013 AAP Guidelines Review Carla M. Giannoni, MD Surgeon, Otolaryngology Texas Children's Hospital Professor, Surgery and Pediatrics, Baylor College of Medicine CDC: Acute Rhinosinusitis
More informationPrefe f rred d t e t rm: : rhi h no n s o inu n s u iti t s
HELP It s my sinuses! An overview of pharmacologic treatment of sinusitis Objectives Identify types of sinusitis and underlying pathology Examine common evidence based pharmacologic treatment for sinusitis
More informationFive New Clinical Guidelines in Primary Care: What we all need to know. Learning Objectives. Clinical Practice Guidelines
Five New Clinical Guidelines in Primary Care: What we all need to know Annie Abraham, MSN, RN, FNP-BC Assistant Clinical Professor Texas Woman s University Dallas, TX Learning Objectives Discuss up-to-date
More informationEconomic evaluation of antibacterials in the treatment of acute sinusitis Laurier C, Lachaine J, Ducharme M
Economic evaluation of antibacterials in the treatment of acute sinusitis Laurier C, Lachaine J, Ducharme M Record Status This is a critical abstract of an economic evaluation that meets the criteria for
More informationEffect of Topical Intranasal Steroid in Management of Otitis Media with Effusion
Med. J. Cairo Univ., Vol. 85, No. 2, March: 761-765, 2017 www.medicaljournalofcairouniversity.net Effect of Topical Intranasal Steroid in Management of Otitis Media with Effusion MEDHAT M. SHARSHAR, M.D.
More informationUpper Respiratory tract Infec1on. Gassem Gohal FAAP FRCPC
Upper Respiratory tract Infec1on Gassem Gohal FAAP FRCPC Anatomy Contents Sinusitis Common Cold Otitis media pharyngitis Epiglottitis Croup Trachitis Sinuses Sinus development Born with ME ( Maxillary,
More informationACUTE MASTOIDITIS IN CHILDREN: SUSCEPTIBILITY FACTORS AND MANAGEMENT
& ACUTE MASTOIDITIS IN CHILDREN: SUSCEPTIBILITY FACTORS AND MANAGEMENT Slobodan Spremo*, Biljana Udovčić Clinic for Otorhinolaryngology, Clinic Center in Banja Luka, Zdrave Korde 1, 78000 Banja Luka, Bosnia
More informationEffectiveness of Grommet Insertion in Resistant Otitis Media with Effusion
Bahrain Medical Bulletin, Vol. 35, No.1, March 2013 Effectiveness of Grommet Insertion in Resistant Otitis Media with Effusion Ali Maeed S Al-Shehri, MD, Fach Arzt* Ahmad Neklawi, MD** Ayed A Shati, MD,
More informationPaediatric Otolaryngology
Paediatric Otolaryngology Antony A Narula MA FRCS FRCS Ed Consultant St Mary s & Ealing Hospitals Hon. Professor, Middlesex University 17 th July 2004 Otology Acute Otitis Media Otitis Media with Effusion
More informationUSAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp)
Improvement objective: : decrease morbidity and mortality due to acute upper (rhinitis, sinusitis, pharyngitis) and lower (bronchitis, pneumonia) respiratory infections through improved case management
More informationFacilitator s Guide. Prescription Writing/Patient Safety Author: Benjamin Estrada, MD, University of South Alabama. Active Learning Module
Facilitator s Guide Prescription Writing/Patient Safety Author: Benjamin Estrada, MD, University of South Alabama Active Learning Module Core Concepts In order to master this topic area, students must
More informationReducing unnecessary antibiotic use in respiratory tract infections in children
Reducing unnecessary antibiotic use in respiratory tract infections in children -a secondary care perspective Dr Conor Doherty (Consultant in paediatric infectious diseases and immunology GGC) Current
More informationRunning head: OTITIS MEDIA AUGMENTIN VERSUS WATCHFUL WAITING 1
Running head: OTITIS MEDIA AUGMENTIN VERSUS WATCHFUL WAITING 1 Evidence Based Critically Appraised Topic Otitis Media and using Augmentin versus watchful waiting Ann Sarutzki-Tucker University of Mary
More informationAntibiotic Consumption in the Community in Ireland REPORT FOR First Half of 2013
Antibiotic Consumption in the Community in Ireland REPORT FOR First Half of 2013 1 Summary: Community Antibiotic Use The rate for Quarter 1 of 2013 (1 st January to 31 st March) was 27.4 Defined Daily
More informationStudy of etiological factors and sensitivity pattern in CSOM
Indian Journal of Basic and Applied Medical Research; December 2015: Vol.-5, Issue- 1, P. 766-770 766-771 Original article: Study of etiological factors and sensitivity pattern in CSOM Paresh Chavan, G
More informationCholesteatoma in children
Cholesteatoma in children British Association of Paediatricians in Audiology London Conference, Jan.2012 Matthew Clark FRCS (ORL-HNS) Consultant Otologist Gloucestershire Royal Hospital Overview: Cholesteatoma
More informationStatement on the use of delayed prescriptions of antibiotics for infants and children
Statement on the use of delayed prescriptions of antibiotics for infants and children Endorsed by the Royal College of General Practitioners Background Delayed prescribing (also known as back up prescribing)
More informationGuidance for Industry Acute Bacterial Otitis Media: Developing Drugs for Treatment
Guidance for Industry Acute Bacterial Otitis Media: Developing Drugs for Treatment DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationGlue ear/grommets Child health
Glue ear/grommets Child health Patient information How to contact us Watford General Hospital West Hertfordshire Hospitals NHS Trust Watford Hertfordshire WD18 0HB If you need this leaflet in another language,
More informationMyringotomy and Grommets Children s Ward Patient information Leaflet
Myringotomy and Grommets Children s Ward Patient information Leaflet Page 1 Myringotomy and Grommets Your child is coming into hospital for insertion of grommet(s). The operation is a day case procedure
More informationDr. Rai Muhammad Asghar Associate Professor of Pediatrics Benazir Bhutto Hospital Rawalpindi
Dr. Rai Muhammad Asghar Associate Professor of Pediatrics Benazir Bhutto Hospital Rawalpindi MANAGEMENT OF THE CHILD WITH COUGH OR DIFFICULT BREATHING Global Burden * Commonest cause of death * 2 million
More informationCAREFUL ANTIBIOTIC USE
Make promoting appropriate antibiotic use part of your routine clinical practice When parents ask for antibiotics to treat viral infections: PRACTICE TIPS Create an office environment to promote the reduction
More informationAXITAB-CV TAB. COMPOSITION :
AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil
More informationThe Child s Ear. Normal? Abnormal? And what do we do next?
The Child s Ear Normal? Abnormal? And what do we do next? Anatomy of the Ear: Outer (External) Ear External Ear: Middle Ear: Inner Ear: Inner Ear: Cochlea Inner Ear: Semicircular Canals Why do we care?
More informationVancomycin Orion , Version 2 Public Summary of the Risk Management Plan
Vancomycin Orion 18.1.2016, Version 2 Public Summary of the Risk Management Plan VI.2 Elements for a Public Summary Vancomycin Orion is intravenously administered glycopeptide antibiotic. It is indicated
More information"Non-invasive Pneumococcal Diseases dynamics & the Host Age" Roman Prymula Ministry of Health, the Czech Republic
"Non-invasive Pneumococcal Diseases dynamics & the Host Age" Roman Prymula Ministry of Health, the Czech Republic Disease Caused by S. pneumoniae S. pneumoniae Eustachian Tube Nasopharynx Pharynx Nasal
More informationChronic Ear Disease. Daekeun Joo Resident Lecture Series 11/18/09
Chronic Ear Disease Daekeun Joo Resident Lecture Series 11/18/09 ETD URIs Viral-induced damage to ET lining resulting in decreased mucociliary clearance Viral invasion of ME mucosa results in inflamm Reflux
More information4/7/13 SINUSITIS WHO ARE WE TREATING? AMANDA SAM CONLEY RN, MSN, CFN, LNC, FNP- BC
SINUSITIS WHO ARE WE TREATING? AMANDA SAM CONLEY RN, MSN, CFN, LNC, FNP- BC 1 DefiniGons Anatomy Review Signs and Symptoms OBJECTIVES Acute Viral vrs. Acute Bacterial Treatment Guidelines ANATOMY REVIEW
More informationReview Article Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials
International Journal of Otolaryngology Volume 2012, Article ID 312935, 15 pages doi:10.1155/2012/312935 Review Article Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials
More informationSession 6. Evaluating the Cost of Pharmaceuticals
Drug and Therapeutics Committee Training Course Session 6. Evaluating the Cost of Pharmaceuticals Trainer s Guide Drug and Therapeutics Committee Training Course Trainer s Guide This document was made
More informationCOMMON UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN
١ ٢ COMMON UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN Dr mostafavi SN Pediatric Infectious Disease Department Isfahan University of Medical Sciences Case 1 ٣ An 18 month old infant brought with high
More informationSTUDY SELECTION AND DATA EXTRACTION:
Pediatrics Treatment and Prevention of Otitis Media John Erramouspe and Catherine A Heyneman OBJECTIVE: To review and summarize recent advances in the treatment and prevention of otitis media (OM). DATA
More informationPaediatric ENT Update for General Practice PPG
Paediatric ENT Update for General Practice PPG Mr Daniel Tweedie MA FRCS(ORL-NHS) DCH Consultant Paediatric ENT, Head and Neck Surgeon Evelina London Children s Hospital Evelina London Children s Hospital
More informationA Study on Drug Prescribing Pattern in Upper Respiratory Tract Infections among Pediatrics in Tertiary Care Hospital, Palakkad
Human Journals Research Article June 2016 Vol.:6, Issue:3 All rights are reserved by Resmi.T.M et al. A Study on Drug Prescribing Pattern in Upper Respiratory Tract Infections among Pediatrics in Tertiary
More informationThe burden of asthma on the US Healthcare system and for the State of Texas is enormous. The causes of asthma are multifactorial and well known.
The burden of asthma on the US Healthcare system and for the State of Texas is enormous. The causes of asthma are multifactorial and well known. There are also indications that rural counties have a higher
More informationEVIDENCE DETECTIVES December 28, 2005 Edward Amores, M.D. Reviewed and edited by P. Wyer, M.D. Part I Question Formulation
EVIDENCE DETECTIVES December 28, 2005 Edward Amores, M.D. Reviewed and edited by P. Wyer, M.D. Part I Question Formulation Clinical Scenario Quite often in the Pediatric ED and at times in the adult ED
More informationHigh dose amoxicillin for sinusitis
High dose amoxicillin for sinusitis Amoxil ( amoxicillin ) is a commonly used penicillin antibiotic. It is produced in tablets (500 mg 875 mg), capsules, chewable tablets and oral suspensions. 6-3-2018
More informationIntroduction. Pediatric tympanoplasty: Decision making and technical aspects. pediatric CHL. specific entities 4/11/2013. Blake C.
Pediatric tympanoplasty: Decision making and technical aspects Blake C. Papsin Introduction pediatric CHL incidence /impact specific entities tympanoplasty ossiculoplasty 1 Tympanoplasty most common otologic
More informationHaemophilus influenzae
Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae
More informationOtoscopy and Tympanometry Revisited Skill Refresher for SLPs
Otoscopy and Tympanometry Revisited Skill Refresher for SLPs Susan Lopez, MA, CCC-A Melanie Randle, MS, CCC-A University of Mississippi Learning Objectives You will learn the diagnostic goals of tympanometry
More informationPertussis immunisation for pregnant women
Pertussis immunisation for pregnant women Introduction The routine childhood immunisation programme has been very effective in reducing the overall numbers of cases of pertussis. Before the introduction
More informationNonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part II: Validation study
ORIGINAL SILMAN, ARICK, ARTICLE EMMER Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part II: Validation study Shlomo Silman, PhD; Daniel S. Arick, MD, FACS;
More informationVaccine Information Statement: PEDIATRIC VACCINES (Multiple)
Vaccine Information Statement: PEDIATRIC VACCINES (Multiple) 1. Your Baby s First Vaccines: What You Need to Know Babies get six vaccines between birth and 6 months of age. These vaccines protect your
More informationGlue ear often follows an ear infection. To learn more, see our articles on Ear infection.
Patient information from the BMJ Group Glue ear In this section What is it? What are the symptoms? How is it diagnosed? How common is it? What treatments work? What will happen? Questions to ask Glue ear
More information4 ENT. 4.1 Bone anchored hearing aids. 4.2 Cochlear implants. (
4 ENT 4.1 Bone anchored hearing aids This commissioning responsibility has transferred to NHS England (http://www.england.nhs.uk/). Queries around treatment availability and eligibility, as well as referrals
More informationNational Newborn Hearing Screening Conference
National Newborn Hearing Screening Conference Aboriginal and Middle Ear Health Harvey Coates, MS, FRACS Paediatric Otolaryngologist Clinical Associate Professor The University of Western Australia It has
More informationRSV infection. Information about RSV and how you can reduce the risk of your child developing a severe infection.
RSV infection Information about RSV and how you can reduce the risk of your child developing a severe infection. What is RSV? RSV is one of the most common respiratory viruses and is spread easily. By
More informationVancomycin Orion , Version 1.0. Public Summary of the Risk Management Plan
Vancomycin Orion 18.6.2015, Version 1.0 Public Summary of the Risk Management Plan VI.2 Elements for a Public Summary Vancomycin Orion is intravenously administered glycopeptide antibiotic. It is indicated
More informationGUIDELINE FOR THE MANAGEMENT OF MENINGITIS. All children with suspected or confirmed meningitis
GUIDELINE FOR THE MANAGEMENT OF MENINGITIS Reference: Mennigitis Version No: 1 Applicable to All children with suspected or confirmed meningitis Classification of document: Area for Circulation: Author:
More informationTECHNOLOGY OVERVIEW: PHARMACEUTICALS
TECHNOLOGY OVERVIEW: PHARMACEUTICALS ISSUE 8.0 OCTOBER 1997 MACROLIDES IN COMMUNITY-ACQUIRED PNEUMONIA AND OTITIS MEDIA based primarily on the Technical Report: A Therapeutic and Economic Evaluation of
More informationStreptococcus Pneumoniae
Streptococcus Pneumoniae (Invasive Pneumococcal Disease) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail or by electronic
More informationEar Nose and Throat ENT 316. Bachelor of Medicine and Surgery; MB, BCh. Fourth. (department council approval)
1* Ear Nose and Throat ENT 316 Basic Information Program Title Bachelor of Medicine and Surgery; MB, BCh Department Offering the Course Ear Nose and Throat Academic Year / Level Fourth Date of Specification
More informationACUTE ADENOIDITIS -An infection & enlargement of the adenoid A disease causing nasal obstruction CHRONIC ADENOIDITIS when adenoid hypertrophied it
ACUTE ADENOIDITIS -An infection & enlargement of the adenoid A disease causing nasal obstruction CHRONIC ADENOIDITIS when adenoid hypertrophied it obstruct posterior nose or Eustachian tube extension of
More information